Catecholamines appear to be deeply involved in the secretion mechanisms of pituitary hormones. Recently ample evidence has been accumulating indicating that gonadotropin and prolactin secretion are regulated by catecholamines (MaCann, 1972) . In the case of growth hormone (GH) a number of studies also suggesting a profound relationship with catecholamines have been reported.
Recently several investigators (Boyd et al, 1970 , Saito et al, 1972 , Yoshimi et al, 1972 reported the stimulatory effect of 1-dopa on GH secretion in humans. Large doses of epinephrine have been reported to increase plasma GH in monkeys (Knobil and Meyer, 1968; Gagliardino, 1968) . In humans the stimulatory effect of epinephrine on GH secretion persisted in the presence of beta adrenergic blockade (Blackard, 1970) . Furthermore, it has been postulated that beta adrenergic blockade stimulates and alpha blockade suppresses GH secretion (Imura et al, 1968 and Blackard, 1968; Werrbach, 1970) .
However, although the studies mentioned above suggest that catecholamines play an important role in the secretion mechanisms of GH, the details are still unclear. Little is known about the role of dopamine and norepinephrine. Besides, there are conflicted data on the effect of epinephrine on GH release in different species. In monkeys two reports agreed about the stimulatory effect of epinephrine. On the other hand, negative results were obtained with epinephrine alone in humans (Rabinowitz, 1966; Schalch, 1967) , but positive results were obtained with epinephrine in the presence of beta adrenergic blockade. Furthermore, an obvious suppressive effect of epinephrine was demonstrated by Hertelendy et al (1969) in sheep and in rats by Takahashi et al (1971) . These results suggest that there are species differences in GH secretion response to epinephrine.
Recently a radioimmunoassay for canine GH has been developed in our laboratory (Tsushima et al, 1971) . The purpose of the present study is to investigate the effect of catecholamine on GH secretion in dogs to observe the mode of its action and to compare the results with those obtained in other species previously reported.
Materials and Methods
All experiments were carried out using adult Japanese mongrel dogs, weighing 8-12kg, following an overnight fast. Animals were utilized for experiments repeatedly with a 10-14 days intervals between experiments. During experiment, animals were unanesthetized and unrestrained except for a long chain connected to a dog collar. After two hours adaptation to the new enviornment of the experiment room, test materials were injected into the brachial vein or infused through an indwelling catheter placed in the jugular vein. Blood samples were obtained from the brachial vein by venipuncture or from an indwelling catheter every 15-20min over 90-180min after the start of experiment.
The blood specimens drawn into heparinized syringes were stored at double antibody radioimmunoassay developed in our laboratory (Tsushima et al., 1971) . Highly purified canine GH (D887A: 2.0 IU/mg) prepared by Dr.
A. E. Wilhelmi was used for iodination and standard. Plasma cortisol was measured by the competitive protein binding method using corticoid binding protein from plasma obtained from pregnant women (Murphy, 1967) . Plasma glucose levels were analyzed by the glucose oxidase method (Huggett and Nixon, 1957 (Blackard, 1970; Werrbach et al, 1970; Hansen, 1971; Imura et al, 1971; Massara et al, 1972; Kansal et al, 1972) . The present study demonstrated the inhibitory effect of alpha adrenergic blockade on GH secretion also in dogs. In order to determine whether or not 1-dopa has to be converted to epinephrine resulting to stimulate GH secretion, we attempted to inhibit dopamine beta hydroxylase with fusaric acid. Fusaric acid has been reported to be a potent inhibitor of dopamine beta hydroxylase (Hidaka et al, 1969; Nagatsu et al, 1970) . Therefore, large doses of fusaric acid are expected to inhibit the conversion of dopamine synthesized from exogenous 1-dopa to norepinephrine. With 40mg/kg of fusaric acid, which was sufficient to deplete endogenous norepinephrine (Nagatsu et al, 1970) , no appreciable change in the stimulatory effect of 1-dopa on GH secretion was observed. This result suggests that 1-dopa given exogenously does not have to be converted to epinephrine to stimulate GH release and that dopamine may play an important role in GH release in the dog.
